Functional characterization of the promoter region of human TNFAIP1 gene

Molecular Biology Reports

Volumn 37, Issue 4, 2010, Pages 1699-1705

  Liu, Mingjun ^a   Sun, Zhenhua ^a   Zhou, Aidong ^a   Li, Hong ^a   Yang, Liping ^a   Zhou, Chang ^a   Liu, Rushi ^a   Hu, Xiang ^a   Zhou, Jianlin ^a   Xiang, Shuanglin ^a   Zhang, Jian ^a,b  

^a HUNAN NORMAL UNIVERSITY   (China)

^b Shanghai Institute of Immunology   (China)

Author keywords

Chromatin immunoprecipitation; Electrophoretic mobility shift assay; Promoter analysis; Sp1; TNFAIP1

Indexed keywords

CELL PROTEIN; TRANSCRIPTION FACTOR SP1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 1; UNCLASSIFIED DRUG; PROTEIN; TNFAIP1 PROTEIN, HUMAN;

ANGIOGENESIS; ARTICLE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CONSENSUS SEQUENCE; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE DELETION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HELA CELL; HUMAN; INFLAMMATION; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; POINT MUTATION; PROMOTER REGION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION REGULATION; ANIMAL; DNA FLANKING REGION; GENETICS; METABOLISM; MOLECULAR GENETICS; MOUSE; PROTEIN BINDING;

5' FLANKING REGION; ANIMALS; BASE SEQUENCE; BINDING SITES; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HELA CELLS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEINS; SEQUENCE DELETION; SP1 TRANSCRIPTION FACTOR;

EID: 77953159717     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-009-9588-1     Document Type: Article

References (19)

1. Wolf FW, Marks RM, Sarma V et al (1992) Characterization of a novel tumor necrosis factor-alpha-induced endothelial primary response gene. J Biol Chem 267:1317-1326
2. Zhou J, Hu X, Xiong X et al (2005) Cloning of two rat PDIP1 related genes and their interactions with proliferating cell nuclear antigen. J Exp Zoolog A Comp Exp Biol 303:227-240. doi: 10.1002/jez.a.150
3. Link CD, Taft A, Kapulkin V et al (2003) Gene expression analysis in a transgenic Caenorhabditis elegans Alzheimer's disease model. Neurobiol Aging 24:397-413. doi:10.1016/S0197-4580(02)002 24-5
4. Zhou J, Ren K, Liu X et al (2005) A novel PDIP1-related protein, KCTD10, that interacts with proliferating cell nuclear antigen and DNA polymerase delta. Biochim Biophys Acta 1729:200-203
5. Yang LP, Zhou AD, Li H et al (2006) Expression profile in the cell lines of human TNFAIP1 gene. Yi Chuan 28:918-922. doi: 10.1360/yc-006-1330
6. He H, Tan CK, Downey KM et al (2001) A tumor necrosis factor alpha- and interleukin 6-inducible protein that interacts with the small subunit of DNA polymerase delta and proliferating cell nuclear antigen. Proc Natl Acad Sci USA 98:11979-11984. doi: 10.1073/pnas.221452098
7. Bigger CB, Melnikova IN, Gardner PD (1997) Sp1 and Sp3 regulate expression of the neuronal nicotinic acetylcholine receptor beta4 subunit gene. J Biol Chem 272:25976-25982. doi:10.1074/ jbc.272.41.25976
8. Inoue T, Kamiyama J, Sakai T (1999) Sp1 and NF-Y synergistically mediate the effect of vitamin D(3) in the p27(Kip1) gene promoter that lacks vitamin D response elements. J Biol Chem 274:32309-32317. doi:10.1074/jbc.274.45.32309
9. Nakamura Y, Kawachi Y, Xu X et al (2007) The combination of ubiquitous transcription factors AP-1 and Sp1 directs keratinocytespecific and differentiation-specific gene expression in vitro. Exp Dermatol 16:143-150. doi:10.1111/j.1600-0625.2006.00528.x
10. Richer E, Campion CG, DabbasBet al (2008) Transcription factors Sp1 and C/EBP regulate NRAMP1 gene expression. FEBS J 275: 5074-5089. doi:10.1111/j.1742-4658.2008.06640.x
11. Haidweger E, Novy M, Rotheneder H (2001) Modulation of Sp1 activity by a cyclin A/CDK complex. J Mol Biol 306:201-212. doi:10.1006/jmbi.2000.4406
12. Lee JA, Suh DC, Kang JE et al (2005) Transcriptional activity of Sp1 is regulated by molecular interactions between the zinc finger DNA binding domain and the inhibitory domain with corepressors, and this interaction is modulated by MEK. J Biol Chem 280:28061-28071. doi:10.1074/jbc.M414134200
13. Liu XW, Lu FG, Zhang GS et al (2004) Proteomics to display tissue repair opposing injury response to LPS-induced liver injury. World J Gastroenterol 10:2701-2705
14. Fiedler U, Reiss Y, Scharpfenecker M et al (2006) Angiopoietin- 2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med 12:235-239. doi: 10.1038/nm1351
15. Danese S, Sans M, de la Motte C et al (2006) Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. Gastroenterology 130:2060-2073. doi:10.1053/j.gastro.2006.03. 054
16. Fiedler U, Augustin HG (2006) Angiopoietins: A link between angiogenesis and inflammation. Trends Immunol 27:552-558. doi:10.1016/j.it.2006.10.004
17. Ryuto M, Ono M, Izumi H et al (1996) Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1. J Biol Chem 271: 28220-28228. doi:10.1074/jbc.271.45.28220
18. Ishibashi H, Nakagawa K, Onimaru M et al (2000) Sp1 decoy transfected to carcinoma cells suppresses the expression of vascular endothelial growth factor, transforming growth factor beta1, and tissue factor and also cell growth and invasion activities. Cancer Res 60:6531-6536
19. Yoshida S, Ono M, Shono T et al (1997) Involvement of interleukin- 8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol Cell Biol 17:4015-4023